Community Health Systems, Inc. filings document the regulatory record of a hospital operator with NYSE-listed common stock and a wholly owned subsidiary that issues senior secured notes, CHS/Community Health Systems, Inc. The company's 8-K reports disclose operating results, Regulation FD information, debt tender offers, senior secured note matters, asset dispositions and related exhibits.
Proxy and governance filings describe board matters, named executive officer compensation, incentive plans and shareholder voting items. Capital-structure disclosures cover common stock registration, senior secured notes due 2031 and 2032, tender-offer mechanics and other material events tied to the company's healthcare delivery assets and outpatient network.
Community Health Systems files a Schedule 13G reporting that He Zhengxu beneficially owns 7,410,784 shares of Common Stock, equal to 5.3% of the class as of 05/14/2026. The filing shows sole voting and dispositive power over the same 7,410,784 shares.
Community Health Systems, Inc. reported the results of its annual stockholder meeting held on May 12, 2026. Stockholders elected 14 directors to serve until the 2027 annual meeting, with each nominee receiving more votes "for" than "against," and substantial broker non-votes recorded on the director items.
Investors also approved a non-binding advisory resolution on executive compensation, with 81,701,049 votes for, 1,814,301 against, and 540,013 abstentions, alongside 27,004,521 broker non-votes. In addition, stockholders ratified Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, by a wide margin.
Community Health Systems, Inc. is moving ahead with a cash tender offer of up to $600,000,000 to repurchase certain senior secured notes through its subsidiary. The company reached its aggregate maximum purchase amount after strong early participation from holders of its 4.750% notes due 2031 and 10.875% notes due 2032.
As of the early tender date, a large majority of the 2031 Notes and a significant portion of the 2032 Notes were tendered, leading to proration and acceptance of specific principal amounts for settlement on an expected early settlement date of May 7, 2026. Notes tendered after the early tender date will not be accepted unless the issuer changes the offer terms.
Community Health Systems is launching a cash tender offer through its wholly owned subsidiary to buy back up to $600,000,000 aggregate purchase price of its outstanding senior secured notes. The offer covers its 4.750% notes due 2031, capped at $350,000,000, and its 10.875% notes due 2032, capped at $250,000,000.
Holders who tender by the May 5, 2026 early tender date are eligible for an extra $50.00 per $1,000 principal, giving total consideration of $950.00 for the 2031 notes and $1,082.50 for the 2032 notes. The offer expires on May 20, 2026 and will be funded with cash on hand, with acceptances based on priority levels, caps and possible proration.
Community Health Systems director K. R. Ranga reported compensation-related equity activity, primarily the settlement of deferred awards into common stock. On April 22, 2026, restricted stock units previously granted and deferred by the director converted into 46,950 shares of common stock through a derivative exercise.
Following this exercise, the director directly owned 156,093 shares of common stock, indicating the shares were retained rather than sold in the market. The director also continued to hold deferred equity, including restricted stock units totaling 228,321 units and stock units under a directors’ fee deferral plan representing 69,653.39 underlying common shares, which will settle later under pre-existing deferral elections.
Community Health Systems, Inc. reported net operating revenues of $2.965 billion for the quarter ended March 31, 2026, down from $3.159 billion a year earlier, though same-store revenues rose modestly. The company posted a net loss attributable to stockholders of $58 million, compared with a $13 million loss in the prior-year quarter, as higher taxes and interest outweighed operating gains and divestiture benefits.
Cash and cash equivalents increased to $712 million, driven largely by $657 million of proceeds from the sale of three Pennsylvania hospitals and an 80% interest in a Tennessee hospital, plus a subsequent $459 million Crestwood Medical Center sale completed April 1, 2026. Community Health Systems continues to reshape its portfolio, classifying additional Arkansas hospitals as held-for-sale, while managing a significant $10.156 billion debt load and negative operating cash flow of $297 million this quarter.
Community Health Systems, Inc. reported weaker results for the quarter ended March 31, 2026. Net operating revenues were $2.965 billion, down 6.1% from $3.159 billion a year earlier, as total admissions fell 10.8% and adjusted admissions declined 10.5%.
The company recorded a net loss attributable to stockholders of $58 million, or $(0.43) per diluted share, compared with a loss of $13 million, or $(0.10) per share, in 2025. On an adjusted basis, net loss per diluted share was $(0.48) versus $(0.03) a year earlier. Adjusted EBITDA declined to $309 million from $376 million.
Operating cash flow turned negative, with net cash used in operating activities of $297 million versus $120 million provided in the prior year period. The company redeemed approximately $223 million of 10.875% Senior Secured Notes due 2032 and continued its divestiture program, selling several hospitals and signing a $112 million asset sale agreement in Arkansas, while reaffirming its 2026 annual earnings guidance.
Community Health Systems, Inc. is asking stockholders to vote at its 2026 Annual Meeting on electing 14 directors, approving executive compensation on an advisory basis, and ratifying Deloitte & Touche LLP as independent auditor for 2026.
The proxy highlights 2025 results: net operating revenues of $12.485 billion, down 1.2% year over year, but same-store net revenues rose 4.6%. Net income attributable to stockholders improved to $509 million from a $(516) million loss, and cash flows from operations increased to $543 million from $480 million.
The company continued major balance sheet actions, including a tender offer for about $584 million of 6⅞% senior unsecured notes due 2028 and new secured note offerings used to refinance 2027 and 2032 maturities. The filing also describes a strong 2025 Say-on-Pay outcome, a largely independent board, and an executive pay program heavily weighted to performance-based and equity incentives.
Community Health Systems, Inc. has completed the sale of substantially all assets of the 180-bed Crestwood Medical Center in Huntsville, Alabama, and related outpatient sites to Huntsville Hospital Health System for $459 million in cash, before certain transaction expenses and subject to a working capital adjustment. The company estimates a pre-tax gain of $185 million, or $138 million after tax, on the divestiture. Pro forma for the sale, 2025 net operating revenues decrease from $12,485 million to $12,158 million, and the net loss attributable to stockholders widens from $509 million to $610 million, reflecting removal of Crestwood’s results and the gain on sale flowing through accumulated deficit rather than recurring income.